Cardiovascular Systems Lowered to Neutral at Zacks (CSII)
Cardiovascular Systems (NASDAQ:CSII) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued on Wednesday, StockRatingsNetwork reports. They currently have a $36.80 price objective on the stock. Zacks‘ price target indicates a potential upside of 10.54% from the company’s current price.
CSII has been the subject of a number of other recent research reports. Analysts at Benchmark Co. upgraded shares of Cardiovascular Systems from a “hold” rating to a “buy” rating in a research note to investors on Thursday, January 30th. They now have a $38.00 price target on the stock, up previously from $35.00. Separately, analysts at Wunderlich raised their price target on shares of Cardiovascular Systems from $34.00 to $41.00 in a research note to investors on Friday, January 10th. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $37.80.
In other Cardiovascular Systems news, VP Robert Thatcher unloaded 35,139 shares of Cardiovascular Systems stock on the open market in a transaction dated Thursday, January 30th. The shares were sold at an average price of $35.06, for a total value of $1,231,973.34. Following the sale, the vice president now directly owns 84,014 shares of the company’s stock, valued at approximately $2,945,531. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Cardiovascular Systems (NASDAQ:CSII) traded down 1.86% during mid-day trading on Wednesday, hitting $32.67. The stock had a trading volume of 219,874 shares. Cardiovascular Systems has a one year low of $15.25 and a one year high of $35.43. The stock’s 50-day moving average is $31.82 and its 200-day moving average is $26.36. The company’s market cap is $887.9 million.
Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings data on Wednesday, January 29th. The company reported ($0.32) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.34) by $0.02. The company had revenue of $32.30 million for the quarter, compared to the consensus estimate of $30.62 million. The company’s revenue for the quarter was up 27.7% on a year-over-year basis. On average, analysts predict that Cardiovascular Systems will post $-1.23 earnings per share for the current fiscal year.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.